.jpg)
.jpg)
University of Rochester Medical Center
Dr. Messing has recently stepped down as Winfield W. Scott Professor and Chairman of Urology at the University of Rochester after over 22 years of service. He is currently Professor of Urology, Oncology and Pathology. Prior experiences include: Interim Director, James P. Wilmot Cancer Center, University of Rochester; Professor, Surgery/Human Oncology, University of Wisconsin Medical School; Chief, Urologic Oncology, Division of Urology, Department of Surgery, University of Wisconsin School of Medicine and Clinical Assistant Professor of Urology, Tulane University School of Medicine.
He is former President of the Society of Urologic Oncology and former co-leader of the GU Committee of the Eastern Cooperative Oncology Group and is currently co-leader of the Renal Cancer Subcommittee of the Southwest Oncology Group. In 2013 he was awarded the prestigious Presidential Citation from the American Urological Association for his work on bladder cancer research and urologic education. He is the 2018 recipient of the Ramon Guiteras Award.
His research includes: early detection, prevention, and treatment of urologic malignancies.
Dr. Messing is a renowned surgeon specializing in urologic cancers and related diseases. Dr. Messing strongly believes research is an integral part of the practice of medicine and is necessary to provide patients with the best possible care. His research interests (he has been an NIH funded investigator for over 25 years) range from basic science investigations into the molecular underpinnings of cancers of the bladder, kidney and prostate, to translational research which has adopted laboratory findings and has brought them to the care of patients, to carrying out large scale studies on screening for, and prevention of these cancers. Furthermore, he has designed and conducted large clinical trials on the treatment of bladder, renal and prostate cancer. His work is often quoted in medical publications, and is frequently asked to be a visiting professor.
Disclosure information not submitted.
Friday, May 13, 2022
3:30 PM – 5:30 PM